Industry News Roundup
This article was originally published in The Tan Sheet
Executive Summary
Pharmavite annexes FoodState; CSPI urges ban on caffeine powder; NCCIH debuts at NIH; Gravity in Hantain’s orbit; SDC Nutrition in Costa Rica, Cayman Islands; Mannatech in Spain; and Food Advisory Committee nominations.
You may also be interested in...
Supplement Industry Critics On Agenda For FDA's Ingredient List Meeting
FDAs Oct. 3 meeting agenda includes Pieter Cohen, Harvard Medical School professor; Consumers Union Programs Director Chuck Bell; Laura MacCleery, Center for Science in the Public Interest regulatory affairs director; and Stephanie Scarmo, Pew Charitable Trusts Health Care Products Project officer.
Roche/Genentech Keeps Commitment To External Cancer Innovation
Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.
US FDA Eases Changes For Certain Sterile Injectable Container Closure Materials
To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: